PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study targets treatment for serious ACE inhibitor side effect

2011-04-29
(Press-News.org) DETROIT – A new Henry Ford Hospital study takes a closer look at one of the lesser known, but potential most serious side-effects of ACE inhibitor use – facial, tongue and airway swelling – and identifies a successful and less invasive course of treatment.

Using a treatment protocol developed by Henry Ford, patients' symptoms were quickly diagnosed and promptly treated to reduce swelling, resulting in no tracheotomies to open the airway or reported deaths, says study author Samer Al-Khudari, M.D.

"This side-effect is rare, but when it happens, it can be anxiety-provoking for both patients and physicians," says Dr. Al-Khudari, a member of the Department of Otolaryngology-Head & Neck Surgery at Henry Ford.

"Our goal was to really take a closer look at the treatment options available and develop a better standard of care for not just otolaryngologist, but all health care providers to follow."

The study will presented April 30 at 114th Annual Meeting of the Triological Society, part of the Combined Otolaryngology Spring Meetings in Chicago.

ACE inhibitors are a popular class of drugs most often prescribed to treat high blood pressure, congestive heart failure and kidney disease, as well as prevent stroke.

While they are well-tolerated by most patients, there are some side effects including angiodema, swelling that occurs in areas of the head and neck (floor of mouth, tongue, lips, throat) and can lead to airway obstruction.

Patients most commonly come into the emergency department experiencing difficulty swallowing, shortness of breath and voice changes.

ACE inhibitor induced angiodema (AIIA) tends to be more common among African Americans.

The study included 40 patients who received care at Henry Ford Hospital over a one-year period. The majority of patients (92%) were African American, and most were taking an ACE inhibitor called Lisinopril.

Treatment for all patients at Henry Ford included IV corticosteroids and antihistamines. On average, medical therapy was initiated by otolaryngology services about one hour after the initial evaluation in the emergency department.

All patients underwent a physical examination and laryngoscopy, which uses a flexible viewing tube to evaluate the back of the throat, including the voice box. Floor of mouth swelling was present in 50% of patients, and massive tongue swelling was found in 11.6%.

About half of the patients were admitted to the intensive care unit, while six required intubation and 14 were monitored and discharged from the ER. None of the patients needed emergency tracheotomy or cricothyrotomy for airway control.

Throughout the course of treatment, inpatients were evaluated at least twice a day by the otolaryngology service, and repeat flexible laryngoscopy was performed based on symptoms. Patients were discharged with or without a tapered steroid dose and scheduled for outpatient follow-up.

For most patients, AIIA was resolved in 27 hours.

"If a patient taking an ACE inhibitor notices intermittent swelling in the mouth, lips, face, the medication may very well be the culprit. When this type of swelling occurs, we recommend that patients contact their health care providers immediately and not wait for symptoms to worsen," says Dr. Khudari.

Regardless, Dr. Khudari says it's very important for patients to note that the benefits of ACE inhibitors greatly outweigh the potential risks.

###

In addition to Dr. Khudari, study authors are Michael J. Loochtan, University of Toledo College of Medicine; and Kathleen L. Yaremchuk, M.D., chair of the Department of Otolaryngology-Head & Neck Surgery at Henry Ford Hospital.

Funding: Henry Ford Hospital

END



ELSE PRESS RELEASES FROM THIS DATE:

Monkey recall memory mirrors that of humans

2011-04-29
A new study shows for the first time that monkeys can recall and reproduce simple shapes from memory. Identifying this recall ability is critical to our understanding of the evolution of memory and other cognitive abilities, and it could be applied to better diagnosing and treating memory impairments in humans. The finding by Emory University psychologists and Yerkes National Primate Research Center researchers Ben Basile and Robert Hampton was published today (April 28) in the journal Current Biology. The psychologists developed a computer touchscreen method to test ...

Shielding body protects brain from 'shell shocking' blast injuries

2011-04-29
Stronger and tougher body armor to shield the chest, abdomen and back may be just what soldiers fighting in the Afghanistan and Iraq wars need to better protect their brains from mild injuries tied to so-called "shell shock," results of a Johns Hopkins study in mice suggest. Such mild trauma, resulting from the initial shock of exploding mines, grenades and improvised explosive devices (IEDs) now accounts for more than 80 percent of all brain injuries among U.S. troops. Some 160,000 American veteran men and women are estimated to have sustained this kind of trauma. "Protecting ...

JAMA study reports on fatty liver disease in children and teens

JAMA study reports on fatty liver disease in children and teens
2011-04-29
INDIANAPOLIS – The largest study of its type has found that neither vitamin E, which is an antioxidant, nor the diabetes drug metformin, successfully reduced liver enzymes in nonalcoholic fatty liver disease in children or teens, according to a paper published in the April 27, 2011 issue of Journal of the American Medical Association. The study also found that in patients with a severe type of fatty liver disease, a biopsy of the liver showed improvement in the injury pattern with vitamin E therapy. Nonalcoholic fatty liver disease is the most common cause of chronic ...

Melatonin might help in controlling weight gain and preventing heart diseases associated with obesity

2011-04-29
University of Granada researchers have proven that melatonin –a natural hormone produced by the body– helps in controlling weight gain –even without reducing the intake of food–, improves blood lipid profile –as it reduces triglicerids–, increases HDL cholesterol and reduces LDL cholesterol. Melatonin is found in small quantities in some fruits and vegetables as mustard, Goji berries, almonds, sunflower seeds, cardamom, fennel, coriander and cherries. Thus, the intake of this kind of food might help in controlling weight gain and preventing heart diseases associated to ...

New gene therapy technique on iPS cells holds promise in treating immune system disease

2011-04-29
(WASHINGTON, April 28, 2011) – Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease (CGD) in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology. CGD prevents neutrophils, a type of white blood cell of the immune system, from making hydrogen peroxide, an essential defense against life-threatening bacterial and fungal infections. Most cases of CGD are a result ...

New immigrants less likely to have premature babies in the first 5 years in Canada: Study

2011-04-29
TORONTO, On – April 28, 2011 – Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital. "Living in poor neighbourhoods has been linked with poor health outcomes, but this study shows that this is not always the case for new Canadians," says Dr. Marcelo Urquia, epidemiologist at the Centre for Research on Inner City Health at St. Michael's Hospital. "For new immigrants, while they have an advantage on avoiding premature ...

Social bonding in prairie voles helps guide search for autism treatments

2011-04-29
Researchers at the Center for Translational Social Neuroscience (CTSN) at Emory University are focusing on prairie voles as a new model to screen the effectiveness of drugs to treat autism. They are starting with D-cycloserine, a drug Emory researchers have shown enhances behavioral therapy for phobias and also promotes pair bonding among prairie voles. Giving female voles D-cycloserine, which is thought to facilitate learning and memory, can encourage them to bond with a new male more quickly than usual. The results are published online and will appear in a future ...

Performance goals needed now for offshore wind turbine industry in US

2011-04-29
WASHINGTON — Structural Integrity of Offshore Wind Turbines: Oversight of Design, Fabrication, and Installation, a new report from the National Research Council's Transportation Research Board, examines standards and practices that could be used to design U.S. offshore wind installations. In order to develop offshore wind energy in the United States, a clear set of requirements is needed, the report says. As the U.S. currently lacks standards, the committee that wrote the report recommends that the U.S. Department of the Interior's Bureau of Ocean Energy Management, ...

Crash sensor boosts safety in warehouses

Crash sensor boosts safety in warehouses
2011-04-29
At the end of a long day on the job, the warehouse employee wants to deposit the last palettes quickly before heading home. With a little too much momentum he steers his forklift toward the shelf and collides with a shelf support. This is an every- day situation in large warehouses in which employees often have to maneuver goods through the narrow aisles, often under time pressure. Even harmless-seeming collisions are not really safe though, because over time they may in fact destabilize the shelf supports. In the worst case, the high-rack storage can come crashing down ...

NIH study finds Avastin and Lucentis are equally effective in treating AMD

2011-04-29
Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD. The report, from the Comparison of AMD Treatments Trials (CATT), was published online in the New England Journal of Medicine on Sunday, May 1, 2011. CATT is funded by the National Eye Institute (NEI), a part of the National Institutes of Health. "Over ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Study targets treatment for serious ACE inhibitor side effect